Radiotherapy vs chemotherapy for low-grade gliomas stratified for genetic 1p loss: efficacy and quality of life benefits [ 2008 - 2012 ]

Research Grant

Researchers: Dr Gail Ryan (Principal investigator) ,  Dr David Walker ,  Dr Elizabeth Hovey ,  Prof David Joseph ,  Prof Mark Rosenthal

Brief description Low-grade glioma is an uncommon malignant brain tumour. Surgery, radiotherapy and chemotherapy delay growth of this tumour, but cure is uncommon. Currently the goal of treatment is to control tumour growth for as long as possible whilst maintaining quality of life. This study compares treatment with radiotherapy with a new form of chemotherapy to see which treatment controls tumour growth most effectively, which produces the least side effects and which results in the better quality of life.

Funding Amount $AUD 410,316.69

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant